David A. Siegel Capricor Therapeutics, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 60,622 shares of CAPR stock, worth $389,799. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,622Holding current value
$389,799% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CAPR
# of Institutions
142Shares Held
12.4MCall Options Held
4.99MPut Options Held
5.52M-
Vanguard Group Inc Valley Forge, PA2.31MShares$14.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$10.5 Million0.0% of portfolio
-
State Street Corp Boston, MA1.47MShares$9.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$6.19 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$3.54 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $157M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...